Figure 2From: Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients Plasma calprotectin levels in patients without (1) or with PAD (2), without (3) or with autonomic neuropathy (4) and without (5) or with MI (6). P-values are from a Mann–Whitney U-test.Back to article page